Research Library

open-access-imgOpen AccessEuropean symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015)
Author(s)
Antonella Muraro,
W. J. Fokkens,
S. Pietikainen,
D. Borrelli,
Ioana Agache,
Jean Bousquet,
Vincenzo Costigliola,
Geza Joos,
Valerie J. Lund,
Lars K. Poulsen,
Darren Price,
Colette Rolland,
Torsten Zuberbier,
P W Hellings
Publication year2015
Publication title
rhinology
Resource typeJournals
PublisherEuropean Rhinologic Society
On 14 October 2015, the European Academy of Allergy and Clinical Immunology (EAACI), the European Rhinologic Society (ERS) and the European Medical Association (EMA) organized a symposium in the European Parliament in Brussels on Precision Medicine in Allergy and Airways Diseases, hosted by MEP David Borrelli and with active participation of the European Respiratory Society (ERS), the European Federations of Allergy and Airways Diseases Patients Associations (EFA), the Global Allergy and Asthma European Network (Ga2len), Allergic Rhinitis and Its Impact on Asthma (ARIA) and the Respiratory Effectiveness Group (REG). MEP Sirpa Pietikainen, Chair of the European Parliament Interest Group on Allergy and Asthma, underlined the importance of the need for a better diagnostic and therapeutic approach for patients with Allergies and Chronic Airways Diseases, and encouraged a joint initiative to control the epidemic of Allergy and Asthma in Europe. The socio-economic impact of allergies and chronic airways diseases cannot be underestimated, as they represent the most frequently diagnosed chronic non-communicable diseases in the EU. Despite the fact that 30% of the total European population is nowadays suffering from allergies and asthma, more than half of these patients are deprived from adequate diagnosis and treatment. Precision Medicine represents a novel approach in medicine, embracing 4 key features: personalized care based on molecular, immunologic and functional endotyping of the disease, with participation of the patient in the decision making process of therapeutic actions, and taking into account predictive and preventive aspects of the treatment. Implementation of Precision Medicine into clinical practice may help to achieve the arrest of the Epidemic of Allergies and Chronic Airways Diseases. This report summarizes the key messages delivered during the symposium by the speakers, including the EU Commissioner for Health and Food Safety Vitenys Andriukaitis. The Commissioner underscored the need for optimal patient care in Europe, supporting joint action plans for disease prevention, patient empowerment and cost-effective treatment strategies leading to a better health status of European citizen
Subject(s)allergen , allergy , asthma , business , disease , economic policy , european community , european union , family medicine , immunology , intensive care medicine , international trade , law , medicine , parliament , pathology , political science , politics , respiratory allergy
Language(s)English
SCImago Journal Rank1.275
H-Index57
eISSN2589-0085
pISSN0300-0729
DOI10.4193/rhino15.400

Seeing content that should not be on Zendy? Contact us.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here